abstract |
FIELD: medicine, ophthalmology, pharmacy. SUBSTANCE: invention proposes 0.2% chelepine D solution in 6% polyglucine in combination with chelepine D tablets. Drug shows antiviral and antiinflammatory total and local effect both at surface and deep keratitis forms combined with stroma damage. Drug can be used for treatment of patients with herpes-viral and adenoviral eye diseases. EFFECT: enhanced effectiveness of drug proposed. 1 cl, 6 ex |